Patrick O'Brien, General Counsel at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 29,150 shares at $60.43 ($1.8M) on 2020-01-06, disclosed to the SEC on 2020-01-08.
Seasonal sale ($1.8M) by General Counsel — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.61 | 5,594 | $333K | 19.0% |
| 2 | $59.61 | 5,594 | $333K | 19.0% |
| 3 | $60.43 | 8,931 | $540K | 30.8% |
| 4 | $60.43 | 8,931 | $540K | 30.8% |
| 5 | $61.02 | 100 | $6K | 0.3% |
| Total | $60.12 avg | 29,150 |
| $1.8M |
| 100% |
| Filing → |
| GLRE | SELL | 2025-05-14 | $267K | — | Filing → |
| ARWR | SELL | 2025-01-07 | $1.3M | — | Filing → |
| ARWR | SELL | 2024-01-05 | $1.9M | — | Filing → |